Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group

BACKGROUND: Interstitial lung disease in systemic sclerosis (SSc-ILD) is a major cause of SSc-related death. Imunosuppressive treatment (IS) is used in patients with SSc for various organ manifestations mainly to ameliorate progression of SSc-ILD. Data on everyday IS prescription patterns and clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Adler, Sabine, Huscher, Dörte, Siegert, Elise, Allanore, Yannick, Czirják, László, DelGaldo, Francesco, Denton, Christopher P., Distler, Oliver, Frerix, Marc, Matucci-Cerinic, Marco, Mueller-Ladner, Ulf, Tarner, Ingo-Helmut, Valentini, Gabriele, Walker, Ulrich A., Villiger, Peter M., Riemekasten, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791165/
https://www.ncbi.nlm.nih.gov/pubmed/29382380
http://dx.doi.org/10.1186/s13075-018-1517-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791165/
https://www.ncbi.nlm.nih.gov/pubmed/29382380
http://dx.doi.org/10.1186/s13075-018-1517-z

Ejemplares similares